Company intelligence / Profile preview

Natural Industries Inc.

Houston, Texas, United Statesfacebook.com ↗

Ownership: Private
Employees: ~24
Development stage: Commercial

Overview

Natural Industries Inc. developed a portfolio of proven biological products and had new pipeline opportunities focused on improving crop yields and controlling diseases in high-value crops. The company was recognized for its expertise in biocontrol solutions that complement traditional chemical pesticides. At the time of acquisition by Novozymes, it had established good market coverage within key U.S. regions.

Therapeutic areas: Other
Modalities: Biological solutions for plant health and disease controlbiocontrol agents
Industry: Agriculture & AgTech

Drug pipeline

1 asset

Actinovate AG

Commercial

Indications: Plant diseases, Agricultural diseases

Beyond the preview

Go deeper on Natural Industries Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural Industries Inc..

Explore the full profile